Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

NCT02237196 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

121

Enrollment

NIH

Sponsor class

Conditions

Cat Allergy
Cat Hypersensitivity

Interventions

BIOLOGICAL: AMG 157
BIOLOGICAL: Cat Immunotherapy
BIOLOGICAL: Cat Immunotherapy Placebo
BIOLOGICAL: AMG 157 Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]